Norman Selby has been active in the healthcare world as a consultant, executive, investor and board member for 30+ years. He is currently Executive Chairman of Real Endpoints llc, an information and analytics company focused on pharmaceutical reimbursement and pricing. He served as Chairman of Physicians Interactive Inc. from 2008 – 2013, when it was sold to Merck. Previously Mr. Selby was president and chief executive officer of TransForm Pharmaceuticals, Inc., a specialty pharmaceutical company which was acquired by Johnson & Johnson, and an executive vice president at Citigroup/Citicorp from 1997 to 2000. Mr. Selby spent most of his career at McKinsey & Company, where he was a senior partner and head of the firm’s Global Pharmaceuticals and Medical Products practice. Mr. Selby serves on the Board of Trustees of the Central Park Conservancy, the Memorial Sloan-Kettering Cancer Center and the National Parks Conservation Association. In addition, he serves on the Board of Directors for Metamark Genetics and Merz Group GmbH. He is also a member of the advisory board of the Harvard Business School's Healthcare Initiative. Mr. Selby holds a B.A. in Architecture from Yale College and an M.B.A. with Distinction from the Harvard Graduate School of Business Administration.